Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study
- PMID: 29304089
- PMCID: PMC5755737
- DOI: 10.1371/journal.pone.0186475
Autoimmune rheumatic diseases increase dementia risk in middle-aged patients: A nationwide cohort study
Abstract
Objective: Dementia is a common neurological disease that substantially affects public health. A previous study revealed that dementia occurs when the body's immune system attacks the cells of the brain, indicating that dementia may be similar to autoimmune rheumatic diseases (ARDs). In the current retrospective cohort study, we focused on middle-aged ARD patients (45 years or older) to investigate the association between ARDs in middle-aged people and dementia by using a nationwide population-based database in Taiwan.
Method: Our study analyzed the medical data of the Taiwanese population from 2001 to 2012, with a follow-up period extending until the end of 2011. We identified middle-aged patients with ARDs by using the Taiwan National Health Insurance Research Database. We selected a comparison cohort from the general population that was randomly frequency-matched by age (in 5-year increments), sex, and index year and further analyzed the dementia risk by using a Cox regression model that considers sex, age, and comorbidities.
Results: The study enrolled 34,660 middle-aged ARD patients (77% female, mean age = 59.8 years) and 138,640 controls. The risk of developing dementia was 1.18 times higher for middle-aged patients with ARDs compared with patients without ARDs after adjustment for age, sex, and comorbidities. Among the patients with ARDs, the subgroups with rheumatoid arthritis, systemic lupus erythematosus, and Sjögren syndrome (SS) were associated with a significantly higher dementia risk (adjusted hazard ratio [HR] 1.14, 95% confidence index [CI] 1.06-1.32; adjusted HR 1.07, 95% CI 0.86-1.34; adjusted HR 1.46, 95% CI 1.32-1.63, respectively). Furthermore, primary SS and secondary SS patients had the highest risks of dementia among all the ADR subgroups (adjusted HR 1.35, 95% CI 1.18-1.54; adjusted HR 1.67, 95% CI 1.43-1.95 respectively).
Conclusion: This nationwide retrospective cohort study demonstrated that dementia risk is significantly higher in middle-aged patients with ARDs compared with the general population.
Conflict of interest statement
Figures

Similar articles
-
Autoimmune rheumatic diseases and the risk of Parkinson disease: a nationwide population-based cohort study in Taiwan.Ann Med. 2018 Feb;50(1):83-90. doi: 10.1080/07853890.2017.1412088. Epub 2017 Dec 20. Ann Med. 2018. PMID: 29224375
-
Incidence and risk factors of mental illnesses among patients with systemic autoimmune rheumatic diseases: an 18-year population-based study.Rheumatology (Oxford). 2025 Mar 1;64(3):976-984. doi: 10.1093/rheumatology/keae203. Rheumatology (Oxford). 2025. PMID: 38579187
-
Sleep disorders and increased risk of autoimmune diseases in individuals without sleep apnea.Sleep. 2015 Apr 1;38(4):581-6. doi: 10.5665/sleep.4574. Sleep. 2015. PMID: 25669189 Free PMC article.
-
The risk of lymphoma development in autoimmune diseases: a meta-analysis.Arch Intern Med. 2005 Nov 14;165(20):2337-44. doi: 10.1001/archinte.165.20.2337. Arch Intern Med. 2005. PMID: 16287762 Review.
-
Polyautoimmunity in Sjögren Syndrome.Rheum Dis Clin North Am. 2016 Aug;42(3):457-72. doi: 10.1016/j.rdc.2016.03.005. Epub 2016 Jun 21. Rheum Dis Clin North Am. 2016. PMID: 27431348 Review.
Cited by
-
Causal relationships between rheumatoid arthritis and neurodegenerative diseases: a two-sample univariable and multivariable Mendelian randomization study.Front Med (Lausanne). 2024 Aug 13;11:1439344. doi: 10.3389/fmed.2024.1439344. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39193017 Free PMC article.
-
Longitudinal Changes in Physical and Cognitive Functions among Participants with and without Rheumatoid Arthritis in Community-Dwelling Middle-Aged and Older Adults.Ann Geriatr Med Res. 2023 Mar;27(1):58-65. doi: 10.4235/agmr.22.0142. Epub 2023 Mar 9. Ann Geriatr Med Res. 2023. PMID: 36890765 Free PMC article.
-
Cognitive impairment in individuals with rheumatic diseases: the role of systemic inflammation, immunomodulatory medications, and comorbidities.Lancet Rheumatol. 2024 Dec;6(12):e871-e880. doi: 10.1016/S2665-9913(24)00190-5. Epub 2024 Nov 11. Lancet Rheumatol. 2024. PMID: 39542002 Free PMC article. Review.
-
The impact of cardiovascular and cerebrovascular disease on the risk of dementia in rheumatoid arthritis: A mediation analysis.Semin Arthritis Rheum. 2024 Dec;69:152570. doi: 10.1016/j.semarthrit.2024.152570. Epub 2024 Oct 11. Semin Arthritis Rheum. 2024. PMID: 39413451
-
Ursolic Acid and Solasodine as Potent Anti-Mycobacterial Agents for Combating Paratuberculosis: An Anti-Inflammatory and In Silico Analysis.Molecules. 2022 Dec 29;28(1):274. doi: 10.3390/molecules28010274. Molecules. 2022. PMID: 36615467 Free PMC article.
References
-
- American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Association; 2013.
-
- Emre M, Cummings JL, Lane RM. Rivastigmine in dementia associated with Parkinson’s disease and Alzheimer’s disease: similarities and differences. J Alzheimers Dis. 2007;11(4):509–19. - PubMed
-
- Mayo Clinic Laboratories Test Catalog. Paraneoplastic Autoantibody Evaluation. 2010;Serum Unit Code 83380.
-
- Kang JH, Keller JJ, Lin YK, Lin HC. A population-based case control study on the association between rheumatoid arthritis and deep vein thrombosis. Journal of Vascular Surgery. 2012;56:1642–48. doi: 10.1016/j.jvs.2012.05.087 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials